Educational issues in clinical pharmacology: Who are our audiences and what are their specialized needs? One specialized need - "Understanding the role of veterinary medicine in public health"

Journal of Clinical Pharmacology

Volumn 42, Issue 7, 2002, Pages 718-730

  Lathers, Claire M ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFTRIAXONE; VETERINARY DRUG;

ARTICLE; CLINICAL PHARMACOLOGY; CURRICULUM; GOVERNMENT; HEALTH EDUCATION; MEDICAL EDUCATION; MEDICAL RESEARCH; ORGANIZATION; PHYSIOLOGY; PRESCRIPTION; PUBLIC HEALTH; VETERINARY MEDICINE; ANIMAL; ANIMAL DISEASE; ANTIBIOTIC RESISTANCE; EDUCATION; EDUCATIONAL MODEL; FORECASTING; HUMAN; LEGAL ASPECT; POLICY; RISK ASSESSMENT; SALMONELLOSIS; UNITED STATES;

ANIMAL; ANIMAL DISEASES; ANTI-INFECTIVE AGENTS; CEFTRIAXONE; DRUG RESISTANCE, BACTERIAL; EDUCATION, PHARMACY; FORECASTING; HUMAN; MODELS, EDUCATIONAL; PHARMACOLOGY, CLINICAL; PUBLIC HEALTH; PUBLIC POLICY; RISK ASSESSMENT; SALMONELLA INFECTIONS; UNITED STATES; VETERINARY DRUGS; ANIMALS; HUMANS;

EID: 0035998748     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/009127002401102669     Document Type: Article

References (46)

1. Ceftriaxone-resistant salmonella infection acquired by a child from cattle
2. Veterinary public health: A new frontier in the fight against human disease
3. Role of veterinary medicine in public health: Antibiotic use in food animals and humans and the effect on evolution of antibacterial resistance
4. Clinical pharmacology of antimicrobial use in humans and animals
5. Risk assessment in regulatory policy-making for human and veterinary public health
6. Endocrine disruptors: A new scientific role for clinical pharmacologists? Impact on human health, wildlife, and the environment
7. Changes in antimicrobial resistance in Salmonella enterica Serovar Typhimurium
8. A multistate outbreak of Escherichia coli O157-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers: The Washington experience
9. Massive outbreak in waterborne Cryptosporidium infection in Milwaukee, Wisconsin: Recurrence of illness and risk of secondary transmission
10. Epidemiology of emerging/re-emerging antimicrobial-resistant bacterial pathogens
11. Foods and microbiological risks
12. Risk analysis and meat hygiene
13. Preliminary estimates of costs of foodborne disease in Canada and costs to reduce salmonellosis
14. Epidemiology of foodborne illness: North America
15. Food-related illness and death in the United States
16. Origins and consequences of antimicrobial-resistant nontyphoidal Salmonella: Implications for the use of fluoroquinolines in food animals
17. Emergence of multidrug-resistant Salmonella enterica serotype Typhimurium DT14 infections in the United States
18. Modeling the impact of virginiamycin resistance in Enteroccus faecium in animals with the recently approved human antimicrobial, Synercid
19. Multiple-drug resistant enterococci: The nature of the problem and an agenda for the future
20. Lessons learned from the past: A guide for the future of clinical pharmacology in the 21st century
21. Evaluation of student achievement and educational outcomes
22. Web-based sharing of cutting-edge teaching strategies
23. Experience-based teaching of therapeutics and clinical pharmacology of antiepileptic drugs: Sudden unexplained death in epilepsy: Do antiepileptic drugs have a role?
24. Clinical pharmacology of antiepileptic drug use: Clinical pearls about the perils of Patty: A clinical pharmacology problem solving (CPPS) unit
25. Clinical geriatric psychopharmacology: Drugs and neuropsychiatric symptoms
26. Development of innovative teaching materials: Clinical pharmacology problem-solving (CPPS) units: Comparison with patient-oriented problem-solving units and problembased learning - A 10-year review
27. Cipro (ciprofloxacin hydrochloride), Ceptaz (Ceftazidime axetil), Nebcin (Tobramycin sulfate), and Rocephin (ceftriaxone sodium)
28. Antimicrobial resistance documents available
29. Miracle drugs vs. superbugs: Preserving the usefulness of antibiotics
30. Antimicrobial use in animal feed-time to stop
31. Historical perspective on risk assessment in the federal government
32. Risk assessment and biological mechanisms: Lessons learned, future opportunities
33. A general framework illustrating an approach to quantitative microbial food safety risk assessment
34. Synercid (quinupristin and dalfopristin) and Zyvox (linezolid)
35. Overcoming antimicrobial resistance by targeting resistance mechanisms